23 results
Thumbnail

D1.428 - Fungal Microbiome Diversity in Urban Forest Decreases Asthma and Allergic Inflammation

Thumbnail

D1.431 - Associations of the composition of intestinal microbiota with the initial manifestations of IgE-mediated food allergy in children 6-12 months old

Thumbnail

D1.433 - The effect of preventive administration of probiotic strain E. coli 083:H24:K31 on selected immune characteristics of eight-year-old children

Thumbnail

- D3.164 - Safety and Efficacy of VIT against Wasp Venom in Patients Older than 60 Years

Thumbnail

- D3.165 - Consistent long term benefit of allergen immunotherapy in patients with allergic rhinitis

Thumbnail

- D3.166 - The mental health of adolescent patients with cat allergy improves with rapid dosing of depigmented cat allergoids

Thumbnail

- D3.167 - Allergoids: Characterising Identity Pre- and Post- Modification Using Compendial and Novel Methods

Thumbnail

- D3.169 - Advantage of IgG reactivity testing for the analytical quantification of allergoids

Thumbnail

- D3.172 - Аllergen-specific immunotherapy in patients with allergic rhinitis

Thumbnail

- D3.173 - Nationwide pivotal registry study on house dust mite immunotherapy in allergic rhinitis patients with or without asthma in China (NAVIGATOR)

Thumbnail

- D3.174 - Comparative analysis of extracts from Cupressus arizonica and Juniperus ashei pollens

Thumbnail

- D3.175 - Tumor Necrosis Factor Receptor 2 (TNFR2) is crucial for the efficacy of Allergen-Specific Immunotherapy in a Pre-clinical Murine Model

Thumbnail

- D3.176 - The value of TNF and IL1RN genes in predicting the clinical efficacy of SCIT in children with asthma

Thumbnail

- D3.177 - Potency of Dermatophagoides spp SLIT tablet compared to US standardized mite in ID testing

Thumbnail

D3.170 - Effectiveness and Safety Study of Subcutaneous Immunotherapy for Respiratory Allergy to Dermatophagoides and Lepidoglyphus Destructor

Thumbnail

D3.389 - Deep Learning-Based Real-Time Identification of Wheezing in Lung Sounds: Applications in Disease Prediction and Early Intervention

Thumbnail

D3.390 - Rationale and Design for ALPHA-ORBIT: a phase 3 trial of navenibart, a monoclonal antibody inhibitor of plasma kallikrein for participants with hereditary angioedema (HAE)

Thumbnail

D3.391 - Results from the ALPHA-STAR Trial, a Phase 1b/2 Single and Multiple Dose Study to Assess the Safety, Tolerability, Clinical Activity, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Navenibart in Participants with Hereditary Angioedema (HAE)

Thumbnail

D3.392 - What information and education is crucial for people with food allergies?

Thumbnail

D3.393 - Daily life with a peanut allergy, as a young adult- an interview study